| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/2008.9.JNS08584 |
| P698 | PubMed publication ID | 19216653 |
| P50 | author | Kaj Blennow | Q28321550 |
| Niklas Marklund | Q42292408 | ||
| Henrik Zetterberg | Q6252048 | ||
| P2093 | author name string | Per Enblad | |
| Elisabeth Ronne-Engström | |||
| Lars Hillered | |||
| P4510 | describes a project that uses | microdialysis | Q3856966 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 1227-1237 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury | |
| P478 | volume | 110 |
| Q55632590 | Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury. |
| Q36955963 | Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies |
| Q48308437 | Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus |
| Q33834835 | Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement |
| Q35589949 | Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? |
| Q28479033 | Assessment of α-synuclein secretion in mouse and human brain parenchyma |
| Q34250254 | Axonal pathology in traumatic brain injury |
| Q47605675 | Biofluid biomarkers of traumatic brain injury. |
| Q38128734 | Biomarkers of cognitive dysfunction in traumatic brain injury |
| Q33873438 | Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury |
| Q34318048 | CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury |
| Q26830132 | Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approach |
| Q26801688 | Consensus statement from the 2014 International Microdialysis Forum |
| Q47133242 | Current Opportunities for Clinical Monitoring of Axonal Pathology in Traumatic Brain Injury |
| Q41598901 | Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury |
| Q34317749 | Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy |
| Q38778638 | Defeating Alzheimer's disease and other dementias: a priority for European science and society |
| Q38784171 | Degradomics in Neurotrauma: Profiling Traumatic Brain Injury |
| Q35212524 | Detrimental effect of genetic inhibition of B-site APP-cleaving enzyme 1 on functional outcome after controlled cortical impact in young adult mice |
| Q40240888 | Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo. |
| Q36622309 | Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease |
| Q38306065 | Further understanding of tau phosphorylation: implications for therapy. |
| Q47980241 | Glycerol accumulation in edema formation following diffuse traumatic brain injury |
| Q47192600 | Impact of static pressure on transmembrane fluid exchange in high molecular weight cut off microdialysis |
| Q38215270 | Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury |
| Q34601506 | Label-free microcavity biosensors: steps towards personalized medicine |
| Q34998341 | Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia |
| Q42151783 | Metabolic crisis after traumatic brain injury is associated with a novel microdialysis proteome. |
| Q37714896 | Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development |
| Q35800921 | Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis |
| Q28385324 | Molecular mechanisms of cognitive dysfunction following traumatic brain injury |
| Q28384455 | Neurochemical profile of dementia pugilistica |
| Q38074833 | Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit |
| Q31119100 | Potential Blood-based Biomarkers for Concussion |
| Q91906780 | Quantitative Proteomic Analysis Reveals Impaired Axonal Guidance Signaling in Human Postmortem Brain Tissues of Chronic Traumatic Encephalopathy |
| Q36825523 | Quantitative assessments of traumatic axonal injury in human brain: concordance of microdialysis and advanced MRI. |
| Q46359161 | Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury |
| Q40294680 | Repetitive Closed-Head Impact Model of Engineered Rotational Acceleration Induces Long-Term Cognitive Impairments with Persistent Astrogliosis and Microgliosis in Mice |
| Q36587769 | Serum Metabolic Profiling Reveals Altered Metabolic Pathways in Patients with Post-traumatic Cognitive Impairments |
| Q36640293 | Serum τ protein as a potential biomarker in the assessment of traumatic brain injury |
| Q37103562 | Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury |
| Q37695162 | Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study |
| Q35589772 | Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion |
| Q41325619 | T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study |
| Q24597181 | Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury |
| Q37094273 | The Differences between Blast-Induced and Sports-Related Brain Injuries |
| Q42712515 | The effect of enriched environment on the outcome of traumatic brain injury; a behavioral, proteomics, and histological study |
| Q47382890 | The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders |
| Q87234847 | The neurological wake-up test does not alter cerebral energy metabolism and oxygenation in patients with severe traumatic brain injury |
| Q37734856 | The role of extracellular Tau in the spreading of neurofibrillary pathology. |
| Q37691554 | Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? |
| Q34204176 | Traumatic brain injury reduces soluble extracellular amyloid-β in mice: A methodologically novel combined microdialysis-controlled cortical impact study |
| Q90599081 | Turmeric Extract Supplementation Reduces Tau Protein Level in Repetitive Traumatic Brain Injury Model |
Search more.